Skip to main content
Journal ArticleOPEN ACCESS

Systemic Therapy for Invasive Bladder Cancer: The Value Proposition

  • Raghavan D
The Oncologist (2016) 21(6) 659-661
DOI: 10.1634/theoncologist.2016-0074
0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy followed by definitive local treatment should be the treatment of choice for otherwise healthy and robust patients with T2b–T4 invasive bladder cancer.

Cite

CITATION STYLE

APA

Raghavan, D. (2016). Systemic Therapy for Invasive Bladder Cancer: The Value Proposition. The Oncologist, 21(6), 659–661. https://doi.org/10.1634/theoncologist.2016-0074

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free